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One pathological hallmark in ALS motor neurons
(MNs) is axonal accumulation of damagedmitochon-
dria. A fundamental question remains: does reduced
degradation of those mitochondria by an impaired
autophagy-lysosomal system contribute to mito-
chondrial pathology? We reveal MN-targeted
progressive lysosomal deficits accompanied by
impaired autophagic degradation beginning at
asymptomatic stages in fALS-linked hSOD1G93A
mice. Lysosomal deficits result in accumulation of
autophagic vacuoles engulfing damaged mitochon-
dria along MN axons. Live imaging of spinal MNs
from the adult disease mice demonstrates impaired
dynein-driven retrograde transport of late endo-
somes (LEs). Expressing dynein-adaptor snapin re-
verses transport defects by competing with
hSOD1G93A for binding dynein, thus rescuing auto-
phagy-lysosomal deficits, enhancing mitochondrial
turnover, improving MN survival, and ameliorating
the disease phenotype in hSOD1G93Amice. Our study
provides a new mechanistic link for hSOD1G93A-
mediated impairment of LE transport to autophagy-
lysosomal deficits and mitochondrial pathology.
Understanding these early pathological events bene-
fits development of new therapeutic interventions for
fALS-linked MN degeneration.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is one of the most com-
mon adult-onset motor neuron (MN) degenerative disorders.
About 10% of ALS cases are familial, of which over 20%
are associated with dominant mutations in Cu/Zn superoxide
dismutase (SOD1) genes (Rosen et al., 1993). Although the
toxic mutant SOD1 gain of function is involved in the patho-
genesis (Ilieva et al., 2009), multiple pathologic factors
contribute to ALS-linked MN loss (Cleveland and Rothstein,2001). However, early pathological changes occurring in spinal
MNs far before the symptomatic stage remain obscure. Trans-
genic mice carrying mutant human SOD1 (hSOD1), especially
hSOD1G93A, are clinically and pathologically similar to human
ALS patients (Gurney et al., 1994), thus serving as reliable fa-
milial ALS (fALS) models to understand the early pathological
events.
Mitochondrial dysfunction, impaired dynamics, and degrada-
tion through mitophagy are associated with major neurodegen-
erative disorders (Chen and Chan, 2009; Sheng and Cai, 2012).
Mutations in SOD1 and non-SOD1 ALS-related genes are asso-
ciated with mitochondrial dysfunction (Cozzolino et al., 2013).
Damaged mitochondria not only produce energy and buffer
Ca2+ less efficiently than healthy ones, but also release harmful
reactive oxygen species (ROS) and initiate apoptotic signaling
cascades (Beal, 1996). Thus, mitochondrial pathology is a com-
mon state that triggers the decline of MN function and survival in
ALS-linked pathogenesis. Proper clearance of those mitochon-
dria via mitophagy in neurons may serve as an early protective
mechanism, limiting the leakage of deleterious mediators from
damaged mitochondria.
Altered mitochondrial transport was reported in fALS-linked
hSOD1G93A, TDP-43, and VAPB-P56S mice (Bilsland et al.,
2010; De Vos et al., 2007; Magrane´ and Manfredi, 2009; Mo´rotz
et al., 2012; Shan et al., 2010). Thus, one of the current hypoth-
eses is that the aberrant axonal accumulation of damaged mito-
chondria could be due to reduced mitochondrial transport. We
previously tested this hypothesis by genetically crossing fALS-
linked hSOD1G93A mice and syntaphilin/ knockout mice. Syn-
taphilin acts as a docking receptor specifically targeting axonal
mitochondria; deleting syntaphilin in mice results in the majority
(70%) of axonal mitochondria in a motile pool (Kang et al.,
2008). We found that the 2-fold increase in axonal mitochondrial
motility in the crossed hSOD1G93A/syntaphilin/ mouse does
not slow ALS-like disease progression (Zhu and Sheng, 2011).
Our findings are consistent with a recent study that mitochon-
drial transport deficits are not sufficient to cause axon degener-
ation in mutant hSOD1 models (Marinkovic et al., 2012), thus
challenging the hypothesis that defective mitochondrial trans-
port contributes to rapid-onset MN degeneration. These obser-
vations raise a fundamental question: does impaired degrada-
tion of damaged mitochondria through the lysosome systemNeuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc. 355
play a more important pathological role during the early asymp-
tomatic stage of fALS-linked mice?
Lysosomal maturation and function in neurons depend on the
proper retrograde transport of late endosomes (LEs) and endo-
lysosomal membrane trafficking (Cai et al., 2010; Lee et al.,
2011); such transport and trafficking events are particularly chal-
lenging in spinal MNs with extended long axons. Our central
hypothesis is that an imbalanced flux between autophagy or
mitophagy induction and subsequent degradation within lyso-
somes will result in autophagic stress and mitochondrial pathol-
ogy in axons, thus causing distal axons to become more vulner-
able to dying-back degeneration. While the pathological roles of
an impaired autophagy-lysosomal system in other neurodegen-
erative diseases were reported recently (Harris and Rubinsztein,
2012; Nixon, 2013), this cellular pathway was not examined in
live spinal MN cultures isolated from disease-stage fALS-linked
mouse models. Thus, it is very significant to investigate endoly-
sosomal trafficking and autophagy-lysosomal maturation and
degradation capacity in the context of both in vivo murine
models and in vitro MNs isolated from adult mice.
In this study, we reveal MN-targeted progressive lysosomal
defects in the hSOD1G93A mice starting as early as postnatal
day 40 (P40), accompanied by an aberrant accumulation of
damaged mitochondria engulfed by autophagosomes in lumbar
ventral root axons. These phenotypes were further confirmed in
cultured spinal MNs, but not dorsal root ganglion (DRG) sensory
neurons, isolated from young adult (P40) hSOD1G93A mice. Our
in vitro and in vivo studies demonstrate that endolysosomal
transport is crucial to maintaining mitochondrial integrity and
MN survival. Such deficits are attributable to impaired retrograde
transport of LEs by mutant hSOD1G93A, which interferes with
dynein-snapin (motor-adaptor) coupling, thus reducing the
recruitment of dynein motors to the organelles for transport.
These deficits can be rescued by elevated snapin expression,
which competes with hSOD1G93A to restore dynein-driven trans-
port. AAV9-snapin injection in hSOD1G93A mice reverses mito-
chondrial pathology, reduces MN loss, and ameliorates the
fALS-linked disease phenotype. Our study reveals a new cellular
target for the development of early therapeutic intervention when
MNs may still be salvageable.
RESULTS
Progressive Lysosomal Deficits in hSOD1G93A MNs
Starting at Asymptomatic Stages
Our previous study demonstrated that the hSOD1G93A mouse
strain (B6.Cg-Tg (SOD1G93A) 1Gur/J) shows noMN loss until dis-
ease onset at P123–P127 and rapidly reaches disease end stage
by P157 ± 9 (Zhu and Sheng, 2011). We asked whether spinal
MNs display any detectable lysosomal deficits at early asymp-
tomatic stages. We chose a lysosome-specific marker for our
study. Antibodies against cathepsin D, a lysosomal aspartic pro-
tease, and LAMP-1 were used to co-immunostain lumbar spinal
cords from P40 wild-type (WT) mice. In SMI32-labeled spinal
MNs, almost all cathepsin D signals colocalized with LAMP-1,
while a substantial number of LAMP-1 puncta were not labeled
by cathepsin D, suggesting that cathepsin D is a reliable lyso-
some marker in MNs in vivo (Figure S1A). Strikingly, in P40356 Neuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc.hSOD1G93A mice, spinal MNs showed a substantially lower in-
tensity of cathepsin D signals (Figures 1A and 1B). Quantitative
analysis revealed a left shift in the distribution of hSOD1G93A
MNs to lower cathepsin D mean intensity relative to that from
age-matchedWT littermates (Figures 1C and 1D). With transmis-
sion electron microscopy (TEM), we observed a reduced density
of morphologically featured lysosomes, characterized by elec-
tron-dense content, in the lumbar spinal MNs from P40
hSOD1G93A mice (1.16 ± 0.14/100 mm2, p = 0.01) compared to
their WT littermates (1.68 ± 0.14/100 mm2) (Figures 1E–1G).
Thus, both light and electron microscopy images consistently
suggest lysosomal deficits in hSOD1G93A spinal MNs at an early
asymptomatic stage.
To characterize lysosomal maturation and autophagic degra-
dation in live MNs, we cultured spinal MNs isolated from adult
diseased mice, combined with transgene expression. These
cultured adult spinal MNs can be well maintained in vitro for
up to 3 weeks (Figures S1B and S1C). Compared to embryonic
MN cultures or cell lines routinely used in the ALS field, adult
MN cultures provide more reliable cell models for investigating
cellular mechanisms underlying adult-onset and spinal MN-tar-
geted pathogenesis. First, we examined the relative density of
cathepsin D in cultured spinal MNs at 7 days in vitro (DIV) iso-
lated from adult (P40 or P65) WT and hSOD1G93A mice.
Cultured hSOD1G93A MNs recapitulated lysosomal deficits
shown in spinal MN slices (Figures 1H–1J), thus establishing
a live MN model for studying adult-onset ALS-linked lysosomal
deficits.
We confirmed the lysosomal deficits in cultured adult
hSOD1G93A MNs by examining mature forms of lysosomal
cathepsin D and cathepsin B, which were specifically labeled
by Bodipy FL-pepstatin A or the cresyl violet fluorogenic sub-
strate CV-(Arg-Arg)2 (Magic Red), respectively. The majority of
Bodipy FL-pepstatin A signals colocalized with cathepsin D in
adult DRG neurons from P80 WT mice (Figure S1D). Some
cathepsin D signals had low or no staining by Bodipy FL-pepsta-
tin A, indicating immature lysosomes. In adult MN cultures from
P40 hSOD1G93A mice, normalized mean intensities of the active
forms of cathepsins B and D were significantly reduced relative
to that of WT littermates (Figures S1E–S1H), which is consistent
in organotypic slice cultures of spinal cords fromP40 hSOD1G93A
mice (data not shown), reflecting impaired lysosomal maturation
at such an early asymptomatic stage.
Next, we asked whether lysosomal deficits become more
robust with disease progression. We examined spinal MNs at
various disease stages, including early asymptomatic (P21 and
P40), presymptomatic (P80), disease onset (P120), and end
stage (P148–P160). Mean intensity of cathepsin D in WT MNs
was relatively stable between P21 and P40 and gradually
increased after P80. Conversely, mean intensity of cathepsin D
in hSOD1G93A MNs progressively decreased to 81.7% ± 3.8%
(p < 0.001) at P40, 73.0% ± 3.2% (p < 0.001) at P80, 35.5% ±
2.6% (p < 0.001) at P120, and 13.0% ± 3.5% (p < 0.001) at
P148–P160 relative to that of aged-matched WT littermates
(Figures 2A and 2B). It is notable that there were increased
non-neuronal lysosomal signals at disease onset (P120) and
end stage (P148–P160). This is likely attributable to glial lyso-
somal activation following glial proliferation (Wootz et al.,
Figure 1. Reduced Lysosomal Density in Spinal MNs from Asymptomatic hSOD1G93A Mice
(A–D) Images and quantitative analysis showing reduced lysosomal density in hSOD1G93A MNs. Lumbar spinal cords from P40 WT (A) or hSOD1G93A mice (B)
were co-immunostained with MN marker SMI32 and lysosome marker cathepsin D. Arrows point to MNs. (A) and (B) show enlarged images (right panels) from
boxed MNs. Integrated intensity of cathepsin D was measured using NIH ImageJ, followed by calibration with the size of the soma and expressed as mean
intensity, which was normalized by the average mean intensity in WTMNs setting as 100% (D). There is a left shift in the distribution of cathepsin Dmean intensity
in hSOD1G93A MNs (C). Data were collected from the total number of MNs (indicated within bars) from six WT and five hSODG93A littermates. G, glial cell.
(E–G) Electron micrographs (E and F) and quantitative analysis (G) showing reduced density of lysosomes with electron-dense contents (red arrows) in the spinal
MNs of P40 hSOD1G93Amice. Boxed area shows enlarged images of lysosomes. Data were analyzed from the total number of micrographs (indicated within bars)
taken from three pairs of littermates. N, nucleus.
(H–J) Images (H) and quantitative analysis (I and J) showing reduced lysosomalmean intensity in culturedMNs isolated from adult (P40 and P65) hSOD1G93Amice.
Neurons were co-immunostained with cathepsin D and MAP2 at 7 DIV.
Scale bars, 20 mm (A, B, and H) and 1 mm (E and F). Data were analyzed from the total number of culturedMNs (indicated within bars) and expressed asmean ± SE
with the Student’s t test (also see Figure S1).
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Figure 2. Progressive Lysosomal Deficits in hSOD1G93A Spinal MNs
(A and B) Images (A) and quantitative analysis (B) show progressive reduction of lysosomal density in spinal MNs from early asymptomatic stage to the disease
end stage. Lumbar spinal cords were co-stained with cathepsin D and the MN marker ChAT.
(C and D) Images (C) and quantitative analysis (D) show no reduction of cathepsin D intensity in WT hSOD1 mice at P150.
(E and F) Images (E) and quantitative analysis (F) show a slight reduction in lysosomal density in DRG neurons at late (P150) disease stages of hSOD1G93A mice.
Scale bars, 20 mm (A, C, and E). All data were expressed asmean ± SEwith the Student’s t test. At least three pairs of littermates were used for each time point and
the total number of MNs for analysis is indicated within bars (B, D, and F) (also see Figure S2).2006), which was evidenced by cathepsin D signals that were
mainly localized in the GFAP-positive astrocytes or Iba1-positive
microglia at the disease end stage (Figure S2A). As a control, the
transgenic mice expressing WT hSOD1 displayed no lysosomal
deficits as late as P150 (Figures 2C and 2D). We also examined
DRG sensory neurons from the same mutant hSOD1G93A mice.
Normalized mean intensity of cathepsin D in DRG neurons was
slightly reduced to 83.7% ± 1.7% of WT levels at the disease358 Neuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc.end stage (Figures 2E and 2F), a much milder reduction
compared to that found in the mutant spinal MNs. There was
no statistical difference in the matured forms of cathepsins
B and D between WT and mutant DRG cultures from pre-
symptomatic (P80) hSOD1G93A mice (Figures S2B–S2E). Thus,
progressive lysosomal deficit is an MN-targeted pathological
event beginning at early asymptomatic stages in hSOD1G93A
mice.
Figure 3. Lysosomal Deficits Associate
with Accumulated AVs in Spinal MNs from
Early Asymptomatic hSOD1G93A Mice
(A–C) Images (A and B) and quantitative analysis
(C) showing p62 ring-like AVs (arrows) in a popu-
lation (21.35% ± 1.76%) of hSOD1G93A spinal
MNs. P40 lumbar spinal cord slices were co-
stained with SMI32 and p62. (Right) Enlarged
views of the boxed MNs are shown. Data were
analyzed from a large number of MNs (n > 1,000)
from the total number of slice sections (indicated
below bars) taken from 19 WT and 14 hSOD1G93A
mice.
(D and E) Images (D) and quantitative analysis (E)
showing the correlation of reduced cathepsin D
density and accumulated p62 structures (white
arrows) in P40 hSOD1G93A MNs. Blue arrows point
to mutant MNs with high cathepsin D density but
no detectable large p62 structures. Pink arrows
indicate WT neurons. Data were analyzed from the
total number of MNs indicated within bars (E)
taken from four pairs of littermates.
(F and G) Images (F) and quantitative analysis (G)
show the colocalization of the majority of p62
structures (85.28%) with mitochondrial markers
cytochrome c (Cyto c) or heat shock protein 60
(HSP60) in spinal MNs from P40 hSOD1G93A mice
(also see Figure S3).
(H and I) Representative images show ubiquitina-
tion of p62-targeted mitochondria in the spinal
MNs from P40 hSOD1G93A mice.
Scale bars, 20 mm (A, B, D, F, and H) and 10 mm (I).
Data were expressed as mean ± SE with the
Student’s t test.Impaired Autophagic Clearance Associates
Mitochondrial Pathology in MN Axons
Our findings raise a question of whether robust lysosome deficits
in the spinal MNs impair autophagic and mitophagic clearance.
To address this issue, we examined lumbar spinal cord slice sec-
tions by co-immunostaining SMI32 and the autophagy marker
p62. The p62 ring-like structures were accumulated in a popula-
tion (21.35% ± 1.76%) of MNs from P40 hSOD1G93A mice (Fig-
ures 3A–3C), but were rarely found in MNs from WT littermates
(0.57% ± 0.26%, p < 0.001). This phenotype was reproduced
in cultured spinal MNs at 7 DIV from P40 hSOD1G93A mice (Fig-
ures S3A and S3B). Interestingly, MNs with large clustered p62
structures showed a more robust reduction in cathepsin D den-
sity relative to that from the mutant MNs with no detectable p62
puncta (p = 0.019) or from WT MNs (p < 0.001) (Figures 3D andNeuron 87, 355–3E). Thus, the extent of lysosomal deficits
correlates with levels of accumulated au-
tophagic vacuoles (AVs). The majority
(85.28%) of p62-labeled vacuoles in the
mutant MNs colocalized with various
mitochondrial markers (Figure 3G),
including cytochrome c (Cyto c), heat
shock protein 60 (HSP60) (Figure 3F), su-
peroxide dismutase 2 (SOD2), or pyru-
vate dehydrogenase (PDH) (Figures S3Cand S3D), representing mitophagic intermediates engulfing
damaged mitochondria, some of which show ubiquitination (Fig-
ures 3H and 3I). Aberrant clustering of P62-labeled mitochondria
in hSOD1G93A MNs supports our hypothesis that lysosomal def-
icits impair degradation of damaged mitochondria.
We examined mitochondrial ultrastructures in lumbar spinal
cords and ventral root axons. Although swollen and vacuolated
mitochondria were observed in hSOD1G93A MN soma (Fig-
ure S4A), mitochondria in ventral root axons displayed more
robust degenerative phenotypes, including fragmentation,
cristae distortions, vacuolization, or swelling and clustering (Fig-
ures 4A and 4D). These phenotypes were readily detectable as
early as P40 in hSOD1G93A mice, but rarely found in WT litter-
mates. Quantitative analysis revealed reduced mitochondrial
density in the soma of spinal MNs and relatively increased370, July 15, 2015 ª2015 Elsevier Inc. 359
Figure 4. Mitochondrial Pathology in the Ventral Root Axons of Early Asymptomatic hSOD1G93A Mice
(A–C) Electron micrographs and quantification show fragmented, vacuolated, and clustered mitochondria (A); increased mitochondrial density (B); and robustly
increased vacuolated mitochondria (C) in the ventral root axons (Vent) of early asymptomatic hSOD1G93A.
(D–G) Electron micrographs (D) and quantification (E–G) show an accumulation of AVs engulfing damaged mitochondria (arrowheads) and multilamellar bodies
(MLBs, arrows) in lumbar ventral root axons from P40 hSOD1G93A mice. Note that clustered mitochondria (right) were found at this early age.
(H) Clustering of p62 AVs in ventral root axons from P40 hSOD1G93A mice. Axon myelin sheaths are outlined with MyelinRed.
(legend continued on next page)
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density in the ventral root axons (p < 0.01) (Figure 4B). No signif-
icant change was observed in mitochondrial density in cortical
MNs and dorsal root axons between P40WT and hSOD1G93A lit-
termates. Only mild mitochondrial vacuolization was seen in
mutant dorsal root axons (Figure S4A). Mitochondrial vacuola-
tion was more robust in ventral root axons (49.90% ± 2.07%)
compared to the soma of MNs (12.12% ± 0.94%) from the
same P40 hSOD1G93A mice (Figures 4C and 4D). Mitochondrial
clustering was further confirmed in ventral root slice sections
by staining axonalmitochondrial marker syntaphilin (Figure S4B).
In addition to alteredmitochondrial ultrastructure, we observed
more striking axonal phenotypes in hSOD1G93A mice as follows:
aberrant accumulation and clustering of multilamellar bodies
(MLBs) and amphisome-like structures engulfing damaged mito-
chondria with collapsed cristae (Figures 4D–4G). These unique
structures were readily found in ventral root axons of P40
hSOD1G93A mice, but were almost absent in age-matched WT
mice. MLBs are altered autolysosomes containing multiple
concentric membrane layers and are associated with various
lysosomal storage diseases (Hariri et al., 2000), while amphi-
somes are intermediate AVs originating from the fusion between
late endocytic vacuoles and autophagosomes (Cheng et al.,
2015). These MLBs and amphisomes also were enriched in
cortical neurons by inhibiting lysosomal cathepsin D proteolysis
(Boland et al., 2008). Furthermore, we crossed the GFP-LC3
transgenic mouse (Mizushima et al., 2004) with the hSOD1G93A
mouse. Colocalization of mitochondria and GFP-LC3-labeled
AVs was readily detectable within axon exit zones in the crossed
mutantmice (Figures4I and4J). TEManalysis confirmed thatdou-
ble-membrane AV-like structures engulfing damaged mitochon-
dria and other degradative materials were clustered within the
axon exit zones (Figures 4K and 4L). Consistently, p62-labeled
AVs were clustered along ventral root axons of P40 hSOD1G93A
mice, but rarely in the age-matched WT (Figure 4H). Thus, our
study suggests impaired autophagy-mitophagy degradation in
MN axons of hSOD1G93A mice at early asymptomatic stages.
Snapin Rescues LE Retrograde Transport by Competing
with hSOD1G93A for Binding to Dynein
Lysosomal maturation in neurons depends on proper LE retro-
grade transport and endolysosomal trafficking (Cai et al., 2010;
Lee et al., 2011), which is driven by dynein motors from distal
processes to the soma. Our findings raise the question of
whether lysosomal deficits in hSOD1G93A MNs reflect altered en-
dolysosomal trafficking. To address this issue, we took advan-
tage of live spinal MN cultures from P40 mice to examine axonal
transport of late endocytic organelles labeled with GFP-Rab7
(see Experimental Procedures). In WT MNs, LEs appeared as
small fine vesicular structures distributed evenly along pro-
cesses. In contrast, they were clustered in larger puncta in pro-
cesses of mutant MNs (Figure 5A). Time-lapse imaging showed(I and J) Aberrant accumulation of LC3-labeled AVs engulfing fragmented mitocho
at P40, P80, and P150 stages. (J) shows zoomed images of the boxed area in (I)
(K and L) Electronmicrographs showing clustered AVs (arrows) engulfing organelle
Ms, myelin sheath.
Data were analyzed from a total number of micrographs indicated within bars (B,
2 mm (A, D, and K), 20 mm (H and I), 5 mm (J), and 500 nm (L) (also see Figure S4predominant retrograde transport of LEs along processes to-
ward the soma in WT MNs (Figures 5B and 5C). However,
hSOD1G93A MNs displayed reduced retrograde transport (p =
0.03), while there was no significant change in anterograde
transport (p > 0.05).
Snapin acts as an adaptor recruiting dynein motors to LEs via
binding to the dynein intermediate chain (DIC), thus coordinating
dynein-driven retrograde transport and endolysosomal traf-
ficking (Cai et al., 2010). LE-loaded dynein-snapin complexes
drive AV retrograde transport after they fuse into amphisomes
(Cheng et al., 2015). Thesemechanisms enable neurons tomain-
tain efficient degradation capacity. To rescue lysosomal deficits
and mitochondrial pathology, we introduced the snapin trans-
gene into mutant hSOD1G93A MNs through lentivirus infection.
Elevated snapin expression enhanced retrograde (p < 0.001),
but not anterograde, transport of LEs (Figures 5D and 5E) and
reduced their clustering in the processes of mutant MNs (Fig-
ure 5A). As a control, expressing the snapinL99K mutant defective
in DIC binding failed to rescue the retrograde transport (Figures
S5A and S5B), further confirming the role of snapin-DIC coupling
in driving LE transport.
It was reported that mutant hSOD1G93A, but not WT hSOD1,
interacts with the DIC (Zhang et al., 2007). This raises the ques-
tion of whether the mutant hSOD1 competes with snapin for
binding the DIC, thus interfering with the snapin-DIC coupling
in recruiting dynein to LEs for retrograde transport (Figure 5I).
To address this question, we immuno-isolated late endocytic or-
ganelles from spinal cords with Dynal magnetic beads coated
with an anti-Rab7 antibody. Association of the DIC with Rab7-
labeled organelles was reduced to 34% in P40 hSOD1G93A
mice compared to that from age-matched WT mice (p < 0.001)
(Figures 5F and 5G). This reduced DIC tethering to Rab7-labeled
organelles was not observed in hSOD1wt transgenic mice (Fig-
ures S5C and S5D). We further showed that the DIC selectively
binds to hSOD1G93A, but not hSOD1wt (Figure 5H). While snapin
binds to the DIC, but not to hSOD1WT and hSOD1G93A under the
same conditions (Figure S5E), overexpressing snapin inhibited
hSOD1G93A-DIC coupling (Figure 5H). These data support our
hypothesis that retrograde transport of LEs is impaired by
hSOD1G93A-DIC interaction, which interferes with the snapin-
DIC complex, thereby reducing dynein recruitment to LEs for
transport (Figures 5F and 5I). By competitively binding to the
DIC, hSOD1G93A and snapin play opposite roles in dynein-driven
LE retrograde transport.
Impaired Retrograde Transport Underlying Lysosomal
Deficits
We thought to ask whether enhancing retrograde transport by
snapin could rescue autophagy-lysosomal deficits in vivo and
in vitro. First, we overexpressed snapin in the spinal cord of
hSOD1G93A mice by injecting AAV9-mChery-P2A-snapin into P0ndria (cytochrome c) in axon exit zones of crossed GFP-LC3/hSOD1G93A mice
.
s in the axon exit zone of P40 hSOD1G93Amice. The red boxwas enlarged in (L).
C, and E–G) and expressed as mean ± SE with the Student’s t test. Scale bars,
).
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Figure 5. Snapin Rescues LE Retrograde Transport by Competing with hSOD1G93A for Binding to Dynein
(A) Images showing distribution of Rab7-labeled organelles in adult spinal MNs from P40 WT or hSOD1G93A mice. Note that LEs in the mutant MNs appeared as
large clusters along processes. Transient snapin overexpression reversed the mutant phenotype (right). Neurites in red boxes were zoomed on the right side.
(B and C) Kymographs (B) and quantitative analysis (C) showing reduced LE retrograde transport in P40 hSOD1G93A MNs. Time-lapse imaging was recorded at 7
DIV for 100 frameswith 2.5-s intervals. In kymographs, vertical lines represent stationary organelles; oblique lines or curves to the left indicate retrograde transport.
(D and E) Kymographs (D) and quantitative analysis (E) showing enhanced LE retrograde transport by expressing snapin transgene in hSOD1G93A MNs. Motility
was quantified from the total number of neurites as indicated in parentheses from three experiments and expressed as mean ± SE with Student’s t test. Scale
bars, 20 mm (A, B, and D).
(F and G) Immuno-isolation (F) and quantitative analysis (G) showing reduced association of the DIC with LEs in hSOD1G93A mouse spinal cords. Data were
analyzed from three repeats and expressed as mean ± SE.
(H) Immunoprecipitation showing competitive binding of snapin and hSOD1G93A with the DIC. Note that snapin inhibits the hSOD1G93A-DIC coupling (green box),
while hSOD1G93A, but not hSOD1wt, reduced the snapin-DIC coupling (red box).
(I) Proposedmodel: snapin serves as an adaptor attaching dynein to LEs through binding to the DIC (left). In hSOD1G93AMNs, the snapin-DIC coupling is blocked
by the hSODG93A-DIC interaction (right), thus impairing LE retrograde transport. Elevated snapin expression reverses the mutant phenotype by competing with
hSOD1G93A for binding the DIC (also see Figure S5).
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mice through the temporal vein, an established in vivo MN gene
delivery procedure (Foust et al., 2010). The majority (>96%) of
SMI32- or NeuN-labeled spinal MNs in P40 mice were infected
(Figures S6A–S6D). There was a significant increase in cathepsin
D mean intensity in both WT and hSOD1G93A spinal MNs of P40
mice after in vivo snapin overexpression (Figures 6A and 6B).
Consistently, quantitative analysis of TEM micrographs (>164
for each) revealed an increased density of morphologically
featured lysosomes in hSOD1G93A spinal cords following in vivo
snapin overexpression (Figures 6C and 6D). In addition, transient
HA-snapin expression in cultured P40 hSOD1G93A MNs signifi-
cantly increased mean intensity (31.59%, p = 0.001) and density
(47.11%, p < 0.001) of Bodipy FL-pepstatin A-labeled mature ly-
sosomes relative to that from the same mutant MNs expressing
HA control (Figures 6E–6G).
Next we asked whether rescuing lysosomal deficits by ex-
pressing snapin in MNs is sufficient to enhance autophagic
degradation capacity. First, we infected cultured adult MNs
with Lenti-mRFP-GFP-LC3, a chimeric LC3 autophagy reporter
tagged to both GFP (acid sensitive) and mRFP (acid stable),
followed by live imaging GFP versus mRFP signals. An autopha-
gosome acquires acidic properties when it matures into an auto-
lysosome. In WT neurons, GFP, but not mRFP, was degraded
rapidly in mature acidic autolysosomes (Figure 6H, top). In
contrast, lysosomal deficits in hSOD1G93A MNs resulted in the
accumulation of immature AVs, within which both GFP and
mRFP signals were retained (Figure 6H, middle). Mander’s coef-
ficient analysis showed an enhanced colocalization ratio of
mRFP and GFP signals in themutant MNs from early asymptom-
atic mice (P40) (Figure 6I), indicating an impaired autophagic
maturation or clearance. Snapin expression fully reversed the
mutant phenotype: GFP underwent rapid degradation (Figures
6H, bottom). Second, we examined p62-labeled AVs in the in-
fected spinal cords of P40 hSOD1G93A mice. Elevated snapin
expression significantly reduced the percentage of MNs display-
ing AV-like structures (Figures 6J and 6K). The rescued pheno-
type was further confirmed in cultured mutant MNs (Figures
S6E and S6F), indicating enhanced autophagic clearance
following snapin overexpression. To provide a mechanistic link
between rescued lysosomal deficits and enhanced dynein-
driven LE retrograde transport, we expressed snapinL99K mutant
defective in DIC binding in P40 hSOD1G93A MNs. In contrast
to the effective rescue capacity by expressing WT snapin, ex-
pressing snapinL99K mutant failed to enhance active cathepsin
D levels (Figures S6G and S6H), failed to reduce p62-labled
AVs (Figure S6I), and further impaired degradation of GFP in
adult hSOD1G93A MNs (Figure S6J). Thus, early deficits in auto-
phagy-lysosomal function in hSOD1G93A MNs can be rescued
effectively by snapin expression both in vitro and in vivo.
Elevated snapin competes with hSOD1G93A for binding to dynein
motors, thereby enhancing endolysosomal trafficking and
maturation.
Enhanced Retrograde Transport Reverses
Mitochondrial Pathology and Reduces Disease
Progression in hSOD1G93A Mice
The sequestration of damaged mitochondria into autophago-
somes and subsequent degradation within lysosomes constitutea key cellular pathway in maintaining mitochondrial quality.
We proposed that snapin-mediated enhancement of auto-
phagy-lysosomal function in hSOD1G93A MNs facilitates the
removal of damaged mitochondria. To test our hypothesis, we
examined mitochondrial ultrastructure in ventral root axons
from P40 WT and hSOD1G93A mice injected with AAV9-snapin
or AAV9 control vector. The robust mitochondrial degeneration,
including fragmentation, cristae distortions, vacuolization,
swelling, and clustering, that was observed in P40 hSOD1G93A
mice (Figures 4A and 4D) was significantly reduced following in-
jection with AAV9-snapin, but remained in mutant mice injected
with control AAV9 vector (Figures 7A–7C). In addition, snapin
overexpression dramatically reduced the number of MLBs in
hSOD1G93A mice axons (Figure 7D). Since those MLBs likely
originated from degenerative mitochondria (Figure 4D), these
in vivo rescue effects support our notion that elevated snapin
expression plays a crucial role in reducing mitochondrial pathol-
ogy by removing damaged mitochondria in the diseased MN
axons.
We further examined axonal mitochondrial membrane poten-
tial (Dcm) and free radical generation, two parameters widely
used to assess mitochondrial integrity. First, by loading live
MNs at 14 DIVwith the fluorescent dye TMRE, which stainsmito-
chondria depending on Dcm, we found a significant decrease
(p < 0.001) in TMRE mean intensity in axonal mitochondria
from adult hSOD1G93A MNs compared to those from age-
matched WT MNs (Figure 7E), indicating mitochondrial depolar-
ization. Transient snapin expression restored mitochondrial
Dcm. Second, we examined superoxide levels in axonal mito-
chondria with MitoSOX Red, a mitochondrion-specific superox-
ide indicator. Parallel imaging of superoxide levels demonstrated
elevated ROSproduction (p < 0.001) in axonal mitochondria from
P40 hSOD1G93AMNs relative toWTMNs, a phenotype that could
be suppressed by snapin overexpression (Figure 7F). These two
experiments further support our hypothesis that enhancing
autophagy-lysosomal activity by expressing snapin removes
damaged mitochondria from axons.
We conducted three lines of in vivo and in vitro experiments to
examine whether expressing snapin has any beneficial impact
on MN survival and disease progression in hSOD1G93A mice.
First, we examined MN loss in lumbar spinal cords following viral
injection. At the early asymptomatic age (P40), no significant dif-
ference was detected in the spinal cord MN counts between WT
and hSOD1G93A mice (p > 0.05) (Figure 7G). When animals
reached the disease end stage (P150), there was a significant
reduction in MN number in hSOD1G93A mice injected with the
AAV9 control vector (p < 0.001) compared with aged-matched
WT mice (Figure 7H). However, such MN loss was reduced
following in vivo snapin overexpression in spinal cords (p <
0.01). Next, we examinedMN survival by performing terminal de-
oxynucleotidyl transferase dUTP nick end-labeling (TUNEL) as-
says. In cultured P40 hSOD1G93A MNs at 14 DIV, 15.83% of
MNs were TUNEL positive, higher than age-matched WT MNs
(p < 0.05) (Figure S7A). Snapin overexpression reduced the
apoptosis rate to 6.51% (p < 0.01). Consistently, P40 hSOD1G93A
MN cultures showed reduced survival rates relative to age-
matched WT MNs; snapin overexpression increased survival
over time. At 14 DIV, hSOD1G93A MNs expressing HA controlNeuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc. 363
Figure 6. Enhancing Retrograde Transport by Snapin Rescues Autophagy-Lysosomal Deficits
(A and B) Images (A) and quantitative analysis (B) showing rescued lysosomal deficits in hSOD1G93A MNs following AAV9-snapin infection. Lumbar spinal cords
from P40 mice were co-immunostained with NeuN and cathepsin D.
(C and D) Electron micrographs (C) and quantitative analysis (D) showing increased density of lysosomes with electron-dense content in the spinal MNs of P40
hSOD1G93A mice after snapin overexpression. Boxed area shows enlarged images of lysosomes.
(E–G) Images (E) and quantitative analysis (F and G) show increased intensity and density of active cathepsin D labeled by Bodipy FL-pepstatin A following snapin
transient expression in adult MN cultures of P40 hSOD1G93A mice.
(H and I) Images (H) and quantitative analysis (I) showing that snapin rescued autophagic flux in adult hSOD1G93A MNs. MNs were co-infected with Lenti-mRFP-
GFP-LC3 andHA-snapin or HA control virus. GFP, but notmRFP, was rapidly degraded inmature acidic lysosomes.Mander’s coefficient reflects the relative ratio
of colocalization between mRFP and GFP signals (I).
(J and K) Images (J) and quantitative analysis (K) showing reduced P62 autophagic structures in the spinal MNs of P40 hSOD1G93A mice following AAV9-snapin
infection. Boxed area shows enlarged images of P62 ring-like structures.
Data were analyzed from the total number of MNs (B, F, G, I, and K) or micrographs (D) (indicated within bars) taken from three pairs of mice (D) or in three
independent experiments, and expressed as mean ± SE with the Student’s t test. Scale bars, 20 mm (A, E, H, and J) or 2 mm (C) (also see Figure S6).
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Figure 7. Snapin Reduces Mitochondrial Pathology and Delays Disease Progression
(A–D) AAV9-snapin infection in hSOD1G93A mouse spinal cords significantly reduced the density of degenerated mitochondria with >50% loss of cristae (A),
removed clusters of damaged mitochondria (B and C), and facilitated clearance of MLBs (D).
(E) Elevated snapin expression reversed depolarized (Dcm) axonal mitochondrial phenotype in the mutant MNs. MNs at 1 DIV were infected with pLenti-snapin-
IRES-GFP or pLenti-HA-IRES-GFP control, followed by loading (20 nM, 15 min) of Dcm-dependent fluorescent dye TMRE at 14 DIV.
(F) Elevated snapin expression reduced mitochondrial oxidative stress in the mutant MNs. Note that axonal mitochondria in hSOD1G93A MNs displayed elevated
superoxide fluorescence, which was reversed by snapin overexpression.
(G and H) In vivo snapin expression significantly increased MN survival in hSOD1G93A mice at disease end stage.
(I) Rota-rod tests detected increased time remained on rota-rod in hSOD1G93A mice injected with AAV9-snapin. Each mouse was placed on an accelerated rod
with speed from 5 to 40 rpm over 3 min. The latency to fall off the rota-rod was recorded.
(J) Elevated in vivo snapin expression extended the lifespan of hSOD1G93A mice. Note that death initiation in hSOD1G93A mice was postponed from P140 in AAV9
control group to P158 in AAV9-snapin group. The average lifespan of hSOD1G93Amice increased to 173 ± 10 days with AAV9-snapin injection, compared to 161 ±
11 days in the AAV9 control group.
Data were analyzed from the total number of micrographs (A–D), MNs (E and F), or spinal cord slices (G and H) indicated within bars in three to six independent
experiments. Animal numbers are indicated within figures (I and J). Data are expressed as mean ± SE with Student’s t test (also see Figure S7).displayed a lower survival rate (36.18%± 5.54%). However, sna-
pin overexpression significantly enhanced survival of the
diseased MNs (75.97% ± 10.22%, p < 0.001) (Figure S7B). Ex-
pressing snapinL99K, a snapin mutant defective in DIC binding,
had no beneficial impact on MN survival (39.48% ± 4.79%,p = 0.66) (Figure S7C). In contrast, this mutant reduced WT
MN survival, likely through its dominant-negative effect on
endogenous snapin.
We evaluated ALS-like disease onset and progression in
hSOD1G93A mice following AAV9-snapin injection. We weighedNeuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc. 365
the animals and tested motor coordination monthly during the
first 3 months of age and then weekly after that. While WT
mice continued to grow with age, snapin overexpression slightly
reduced bodyweight in both female (5%) andmale (10%)WT
mice at 26 weeks old (Figures S7D and S7E). However, both
male and female hSOD1G93A mice began to lose weight at
age 17–18 weeks; such weight loss was not affected by snapin
overexpression. Rota-rod tests detected increased time re-
mained on rota-rod in hSOD1G93A mice injected with AAV9-sna-
pin, indicating improved motor coordination after disease onset
(Figure 7I). Notably, the initiation of death in hSOD1G93A mice
was postponed from P140 in the control group to P158 in
the AAV9-snapin group. The average lifespan of hSOD1G93A
mice increased to 173 ± 10 days with AAV9-snapin injection,
compared to 161±11 days in the AAV9-control group (Figure 7J).
WT mice with AAV9-snapin injection stayed alive throughout the
duration of the experiment. Overall, reversing lysosomal deficits
in hSOD1G93A mice by in vivo snapin overexpression in spinal
cords delayed disease progression.
DISCUSSION
In this study, we revealed for the first time that spinal MN-tar-
geted progressive lysosomal deficits start as early as at P40
asymptomatic stages in fALS-linked hSOD1G93A mice. These
deficits impair autophagic/mitophagic degradation, thus result-
ing in an aberrant accumulation of AVs engulfing damaged mito-
chondria along ventral root axons. These pathological pheno-
types were captured in cultured adult (P40) spinal MNs, but
not in DRG sensory neurons from the same hSOD1G93A mice.
Such early deficits are due to reduced LE retrograde transport
via competitive binding of hSOD1G93A to the DIC, and they could
be reversed by introducing snapin transgene in MNs. Snapin
competes with hSOD1G93A for binding to the DIC, thereby re-
cruiting dynein to LEs for retrograde transport. Thus, snapin
and hSOD1G93A play opposite roles in LE retrograde transport.
Furthermore, we showed that expressing snapin efficiently re-
verses autophagy-lysosomal deficits and facilitates the removal
of damaged mitochondria, thereby prolonging mutant MN sur-
vival. Injecting AAV9-snapin into the diseased mice rescued
lysosomal deficits in MNs in vivo and slowed MN degeneration
and disease progression. Thus, our study advances our under-
standing of early pathological mechanisms underlying MN
degeneration and also provides new mechanistic insights into
the following: (1) how mutant hSOD1 impairs LE retrograde
transport by interfering with motor-adaptor coupling, thus
reducing dynein-cargo attachment; and (2) how elevated snapin
expression reverses the mutant phenotypes by competing with
hSOD1G93A for dynein-driven retrograde transport (Figure 5I).
Lysosomal Deficit Is an Early Pathological Phenotype
in hSOD1G93A Mouse MNs
We revealed progressive lysosomal deficits in hSOD1G93A spinal
MNs with disease progression. There are three notable features
in our observations as follows: (1) lysosomal deficits are MN tar-
geted; (2) lysosomal deficits can be detected inmutantMNs from
as early as P40 asymptomatic hSOD1G93A mice, and become
progressively worse after disease onset at P120 when MN loss366 Neuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc.was reported in hSOD1G93A mice (Lambrechts et al., 2003);
and (3) these lysosomal deficits are not observed in WT
hSOD1 transgenic mice even as late as P150. These restricted
and progressive changes highlight a mechanistic link between
lysosome deficits and fALS-linked pathogenesis in spinal MNs.
The increased cathepsin D signals restricted in glial cells after
disease onset in hSOD1G93A mice (Figures 2A and S2A) may
reflect lysosomal activation following glial cell proliferation in
the spinal cords.
Lysosomal Deficits Augment Mitochondrial Pathology
Autophagic flux is the equilibrium balance between autophagic
formation and clearance. Since neurons are particularly sensitive
to the accumulation of misfolded proteins and damaged organ-
elles, newly formed autophagosomes are eliminated quickly by
fusing with endolysosomes, thereby avoiding a buildup of AVs
(Maday et al., 2012; Cheng et al., 2015). However, AVs accumu-
late rapidly in neurons when lysosomal proteolysis is inhibited
(Lee et al., 2011). Impaired autophagic clearance also was re-
ported in various lysosomal storage disorders (Kiselyov et al.,
2007; Settembre et al., 2008). The accumulation of dysfunctional
mitochondria is associated with a primary lysosomal defect in a
mousemodel of neuropathic Gaucher disease, an inherited lyso-
somal storage disorder (Osellame and Duchen, 2014). Thus, an
imbalanced autophagic flux between enhanced autophagy/mi-
tophagic induction and reduced clearance due to lysosomal def-
icits results in autophagic stress characterized by accumulated
AVs engulfing protein aggregates and damaged organelles,
such as mitochondria.
Altered autophagy was reported in fALS-linked mouse
models. Autophagy receptor p62 colocalizes with hSOD1G93A
in fALS mouse spinal MNs (Gal et al., 2007) and interacts with
mutant hSOD1G93A, but not WT hSOD1WT. Overexpressing p62
facilitates engulfing hSOD1G93A aggregates into autophago-
somes for degradation. This is consistent with our findings
showing the p62 ring-like structures accumulated in MNs from
P40 hSOD1G93A mice (Figures 3A–3C). Interestingly, MNs with
large p62 structures showed more robust lysosomal deficits
(Figures 3D and 3E), thus impairing AV clearance. Our study sug-
gests that early lysosomal deficits in hSOD1G93A MNs lead to au-
tophagic defects. Because mitochondrial pathology is a robust
hallmark in fALS-linked MNs at asymptomatic stages, we as-
sessed snapin rescue effects in both in vitro and in vivo
hSOD1G93A mouse models by focusing on mitochondrial pathol-
ogy phenotypes, including ultrastructural changes, mitochon-
drial membrane potential (Dcm), and free radical generation.
Although increased numbers of autophagosomes were
observed in the spinal cords of sALS patients and hSOD1G93A
mice during late disease stages (Li et al., 2008; Morimoto
et al., 2007), the contribution of altered autophagy to the fALS-
linked pathogenesis has been a subject of debate. It remains un-
clear whether enhanced induction of autophagy helps remove
toxic mutant protein aggregates or instead facilitates MN degen-
eration. In vivo treatment of hSOD1G93A mice with rapamycin, an
autophagy inducer via themTOR-signaling pathway, augmented
MN degeneration and disease progression and failed to reduce
mutant hSOD1 aggregates in the spinal cords (Zhang et al.,
2011). However, inducing mTOR-independent autophagy in
hSOD1G93A mice prolonged their lifespan and attenuated the
progression of disease phenotypes (Castillo et al., 2013). Studies
using lithium, an mTOR-independent autophagy inducer (Sarkar
et al., 2005), reported controversial results in the same
hSOD1G93A mice. While one study showed that activating auto-
phagy reduced MN loss in hSOD1G93A mice (Fornai et al., 2008),
two studies found that it caused an earlier onset of the disease
and a reduced lifespan (Gill et al., 2009; Pizzasegola et al.,
2009). Clinical trials by administering therapeutic doses of lithium
showed no effect in ALS patients (Chio` et al., 2010).
These controversial findings raise a question of whether the
observed AVs in fALS-linked spinal MNs reflect enhanced auto-
phagy induction or impaired autophagic clearance. Addressing
this question is critical for future therapeutic strategies for ALS
clinical trials. Our study provides in vitro and in vivo evidence
that progressive lysosomal deficits combined with impaired
degradation of damagedmitochondria are the early pathological
events in hSOD1G93A spinal MNs. The striking AV accumulation
in ventral root axons suggests impaired retrograde transport of
autophagosomes and impaired degradation of damaged mito-
chondria as early as at P40. Our findings provide a clue as to
why inducing autophagy alone, without compensatory rescue
of LE transport and lysosomal deficits, failed to reduce mutant
hSOD1 aggregates in the spinal MNs. Instead it augments MN
degeneration and disease progression (Zhang et al., 2011),
possibly due to enhanced autophagic stress and mitochondrial
pathology. Our recent study revealed that the LE-loaded
dynein-snapin complex drives the retrograde transport of axonal
autophagosomes upon their fusion into amphisomes (Cheng
et al., 2015). Efficient dynein-snapin coupling may help remove
axonal autophagosomes engulfing aggregated proteins and
dysfunctional organelles. Accumulation of vacuolated and
dysfunctional mitochondria within distal axons early in the dis-
ease course can have catastrophic consequences by triggering
axonal degeneration and denervation. This view is consistent
with the notion that ALS is a dying-back type of neuropathy
that initiates and progresses from distal to proximal portions of
MNs (Fischer et al., 2004). Such early autophagic stress and
mitochondrial pathology expedite progressive MN degenera-
tion. Therefore, enhancing lysosomal function, rather than
autophagy induction, is an alternative therapeutic strategy for
ALS-linked clinical trials.
Impaired Retrograde Transport Underlying Autophagy-
Lysosomal Deficits
Intracellular transport is fundamental for maintaining neuronal
homeostasis and survival. In axons, dynein is a minus-end-
directed motor that drives the retrograde transport of degrada-
tive organelles from axonal terminals to the soma where mature
lysosomes are mainly localized, thus facilitating endolysosome
membrane trafficking and lysosomal maturation (Ravikumar
et al., 2005). Altered axonal transport was implicated in the
ALS-associated pathogenesis (De Vos et al., 2007; Perlson
et al., 2009; Williamson and Cleveland, 1999). In vivo analysis
demonstrated axonal retrograde transport deficits in sciatic
MNs, but not in sciatic DRG sensory neurons, of presymptomatic
hSOD1G93A mice (Bilsland et al., 2010). These deficits become
even worse at the symptomatic stage. Consistently, mutationsin dynein motors or genes that regulate dynein-mediated retro-
grade transport cause fALS-like pathology andMNdegeneration
in mice and human patients (Dion et al., 2009; Hafezparast et al.,
2003). Defects in retrograde transport retain late endocytic or-
ganelles and immature AVs engulfing damaged mitochondria
and protein aggregates within axons, rather than being delivered
to the soma for degradation. This is confirmed by our TEM
observations showing an aberrant accumulation of autophagy-
mitophagy intermediates in ventral root axons, and by our immu-
nohistostaining showing clustered LC3-labeled AVs, some of
which colocalized with mitochondria, within axons of the
crossed hSOD1G93A/GFP-LC3 mice. Thus, our study provides
clues that dynein-driven LE transport is essential for maturation
and degradation of the autophagy-lysosome system in MNs.
Mutant hSOD1 Impairs Retrograde Transport by
Interfering with the Snapin-Dynein Complex
Our findings prompt us to address mechanistic questions as to
how mutant hSOD1 impairs LE transport and how snapin res-
cues this transport deficit. Mutant hSOD1 forms aggregates
with the dynein complexes in the spinal MNs of asymptomatic
hSOD1G93A mice, and these aggregates interfere with axonal
transport (Ligon et al., 2005; Sasaki et al., 2005). Three mutant
forms of hSOD1 (G93A, G85R, and A4V), but not WT hSOD1WT,
interact with the DIC (Zhang et al., 2007). These mutant hSOD1-
DIC complexes were readily found in fALS-linked mice at the
presymptomatic stages and increased with disease progression
(Stro¨m et al., 2008), suggesting that dynein is a possible target of
mutant hSOD1 toxicity. However, these studies raise a mecha-
nistic question as towhethermutant hSOD1 aggregates interfere
with the dynein-cargo attachment. It is particularly relevant
because snapin acts as a dynein adaptor specific for LEs via
binding the DIC (Cai et al., 2010). We propose that the
hSOD1G93A-DIC interaction interfereswith snapin-DIC-mediated
recruitment of dynein motors to LEs, thus reducing their retro-
grade transport in hSOD1G93A MNs (Figure 5I).
We found reduced association of dynein DIC with Rab7-
labeled late endocytic organelles in P40 hSOD1G93A spinal
cords compared to those from age-matched WT mice. Such
reduced dynein tethering to LEs was not observed in age-
matched hSOD1wt transgenic mice, suggesting a phenotype
specifically associated with hSOD1G93A expression. Expressing
snapin inhibits the hSOD1G93A-DIC coupling, indicating compet-
itive binding of snapin and hSOD1G93A with the DIC. Thus, our
study reveals a new mechanistic pathway through which mutant
hSOD1 selectively impairs LE retrograde transport, which can
be reversed by elevated snapin expression. We further showed
that introducing snapin transgene into cultured adult MNs and
an in vivo mouse model rescued autophagy-lysosomal deficits,
facilitated removal of damaged mitochondria, and reduced MN
death. Importantly, AAV9-snapin injection improved the motor
coordination and prolonged the average lifespan of hSOD1G93A
mice for 12 days in the current study. This is comparable to
those studies that, by directly inhibiting cytochrome c-induced
MN apoptosis (Zhu et al., 2002) or by reducing the disease-
modifier Epha4 signaling (Van Hoecke et al., 2012), both
increased survival for about 11 days in the same mouse model.
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rescues autophagy-lysosomal deficits caused by hSOD1G93A
and ameliorates the disease phenotype in this disease mouse
model.
Because snapin plays multivalent roles in intracellular traf-
ficking, we cannot exclude the possibility that it also improves
MN viability through other trafficking pathways, such as synaptic
vesicle trafficking and synchronized fusion (Pan et al., 2009) and
retrograde transport of signaling endosomes (Zhou et al., 2012).
Interestingly, expressing the snapinL99K mutant defective in DIC
binding failed to rescue autophagy-lysosomal deficits or reduce
cell death in hSOD1G93A MNs, further supporting that snapin/
dynein-mediated transport plays a major role in restoring auto-
phagy-lysosomal function and delaying MN degeneration.
In summary, our study reveals that lysosomal deficits and
mitochondrial pathology in early asymptomatic hSOD1G93A
MNs are attributable to mutant hSOD1-induced impairment of
endolysosomal trafficking. These early pathological changes
impair the degradation of damaged mitochondria from distal
axons of spinal MNs, thus causing them to be more vulnerable
to dying-back degeneration. Elucidation of this early patholog-
ical mechanism is broadly relevant, because defective
retrograde transport, lysosomal deficits, autophagic stress,
andmitochondrial pathology are all associatedwithmajor neuro-
degenerative diseases, including ALS, Huntington’s, Parkin-
son’s, and Alzheimer’s diseases (Nixon, 2013). Therefore,
enhancing clearance of damaged mitochondria and mutant pro-
tein aggregates by regulating endolysosomal trafficking may be
a potential therapeutic strategy for ALS and perhaps other
neurodegenerative diseases.EXPERIMENTAL PROCEDURES
Additional information can be found in the Supplemental Experimental
Procedures.
Mouse Lines
B6.Cg-Tg (SOD1G93A)1Gur/J mice expressing high copy number of the G93A
mutant form of human SOD1 and B6SJL-Tg(SOD1)2Gur/J mice expressing
WT human SOD1 were purchased from The Jackson Laboratory. Animal
care and usewere carried out in accordancewith NIH guidelines and approved
by the NIH, NINDS/NIDCD Animal Care and Use Committee.
Adult MN Cultures
Mouse spinal cords were extruded from the decapitated neck and sectioned
transversely at 500-mm thickness. After dissociation with 36 units/ml papain
and 0.02% DNase I for 30 min at 30C, the tissue suspension was centrifuged
and the pellet was triturated three times with glass pipettes. After cell
debris and tissue pieces were filtered through a 70-mm cell strainer, the MN
suspension was enriched through OptiPrep gradient centrifugation and was
re-suspended and plated on coverslips coated with 30 mg/ml poly-L-ornithine
and 1 mg/ml laminin. MNs from paired WT and SOD1G93A littermates at early
asymptomatic ages (P40 or P65) were plated on coverslips at the density of
1,000 cells per 12-mm coverslip.
Assays for Mature Cathepsins B and D
To label active cathepsin D in mature lysosomes, live adult MNs or DRG neu-
rons were incubated with 1 mM Bodipy FL-pepstatin A in culture medium for
1 hr at 37C. The active form of cathepsin B was labeled by the cresyl violet
fluorogenic substrate CV-(Arg-Arg)2 (Magic Red). Briefly, live neurons were
incubated with staining solution (MR-RR2) at 1:1,300 dilution for 15 min at
37C, then washed three times by HA medium for imaging. Reduced staining368 Neuron 87, 355–370, July 15, 2015 ª2015 Elsevier Inc.of Bodipy FL-pepstatin A or Magic Red in neurons reflects impaired lysosomal
maturation.
Assay for Autophagic Maturation
Neurons were infected with lentivirus expressing mRFP-GFP-LC3. As soon as
autophagy is induced, GFP, but not mRFP, undergoes rapid degradation in
mature autolysosomes. Lysosomal defects result in both GFP and mRFP co-
localized signals retained in immature autophagosomes. Colocalization be-
tween RFP-LC3 and GFP-LC3 signals was analyzed using ImageJ JACoP
(NIH) withMander’s overlap coefficient. The signals were extracted from back-
ground by setting an appropriate threshold and by applying Gaussian blur to
remove the background noise. Mander’s overlap coefficient was calculated
as the percentage of pixel intensity of GFPmergedwith RFP relative to the total
RFP intensity, with 1 being full colocalization and 0 indicating no colocalization.
Statistical Analysis
Statistical analysis was carried out using Prism (GraphPad). Two groups were
compared using F test orMann-Whitney (sample size n < 30) or Student’s t test
(sample size nR 30). Data are expressed as mean ± SEM. Differences were
considered significant with p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2015.06.026.
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